Hebei Weimiao Biology Co., LTD 1
Location

Oct . 12, 2024 08:18 Back to list

19608-29-8



The compound with the identifier 19608-29-8 is commonly known as Lazabemide. This chemical is part of a broader class of compounds often explored for their therapeutic properties, particularly in the context of neuropsychological disorders. Understanding Lazabemide and its mechanisms can provide insight into potential treatments for various conditions, particularly depression and neurodegenerative diseases.


Lazabemide functions primarily as a selective and reversible inhibitor of the enzyme monoamine oxidase type B (MAO-B). This enzyme plays a crucial role in the breakdown of neurotransmitters such as dopamine, norepinephrine, and serotonin. By inhibiting MAO-B, Lazabemide helps increase the levels of these neurotransmitters in the brain. This action is particularly significant for conditions where neurotransmitter levels are disrupted, such as in Parkinson's disease or major depressive disorder.


The compound with the identifier 19608-29-8 is commonly known as Lazabemide. This chemical is part of a broader class of compounds often explored for their therapeutic properties, particularly in the context of neuropsychological disorders. Understanding Lazabemide and its mechanisms can provide insight into potential treatments for various conditions, particularly depression and neurodegenerative diseases.


Research into Lazabemide extends beyond its basic pharmacological properties. Clinical studies have explored its effects in various patient populations, illustrating its potential utility in combination therapies. Understanding how Lazabemide interacts with other medications can enhance its therapeutic efficacy and provide new avenues for treating refractory cases of depression or Parkinson's disease.


19608-29-8

19608-29-8

Moreover, the reversible nature of Lazabemide's action on MAO-B is an important aspect of its profile. Unlike irreversible inhibitors, which permanently deactivate the enzyme, reversible inhibitors like Lazabemide allow for more flexible management of drug interactions and side effects. This might lead to improved tolerability for patients, which is a crucial factor in the long-term management of chronic conditions.


As research progresses, the full potential of Lazabemide continues to unfold, opening doors for innovative treatment approaches. Ongoing studies are focused not only on its efficacy but also on its safety profile and the mechanisms underlying its therapeutic effects. The continued exploration of compounds like Lazabemide highlights the importance of understanding the biochemical foundations of mental health and neurodegenerative disorders.


In conclusion, Lazabemide (19608-29-8) represents a promising candidate in the quest for effective treatments for mood disorders and neurodegenerative diseases. Its unique properties as a reversible MAO-B inhibitor make it an intriguing option for enhancing neurotransmitter levels in a safe and manageable way. As research continues, Lazabemide could play a pivotal role in the future of psychiatric and neuropharmacological treatments.


Share
Next：

Latest news

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Hit enter to search or ESC to close
en_USEnglish
afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina zh_TWChina (Taiwan) coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek guGujarati htHaitian Creole haHausa hawHawaiian he_ILHebrew hi_INHindi hmnMiao hu_HUHungarian is_ISIcelandic igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian orOccitan psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian smSamoan gdScottish Gaelic sr_RSSerbian stSesotho snShona sdSindhi si_LKSinhala sk_SKSlovak sl_SISlovenian soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil tt_RUTatar teTelugu thThai tr_TRTurkish tkTurkmen ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu en_USEnglish